Sara Nochur - 26 Jan 2023 Form 4 Insider Report for MARINUS PHARMACEUTICALS, INC.

Role: Director
Signature: /s/ Debra A. Mohollen, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 26 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 30 Jan 2023, 15:21:08 UTC
Previous filing: 21 Jun 2022
Next filing: 14 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRNS	Common Stock	Award	$0	+3,600	+131%	$0.000000	6,350	26 Jan 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRNS	Stock Option (Right to Buy)	Award	$0	+16,200		$0.000000	16,200	26 Jan 2023	Common Stock	16,200	$5.94	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the grant of restricted stock units (RSUs). The RSUs vest in full on January 26, 2024, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer.
F2	The option vests and becomes exercisable in 12 equal monthly installments beginning on February 26, 2023, subject to the reporting person's continued service with the Issuer.